Allan J. Collins

Allan J. Collins's AcademicInfluence.com Rankings

Allan J. Collins

Philosophy

#5415

World Rank

#8207

Historical Rank

Logic

#2704

World Rank

#3734

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Allan J. Collins's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Allan J. Collins Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Allan J. Collins's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

K/DOQI clinical practice guidelines for chronic kidney disease (2002) (8858)
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. (2003) (2521)
K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease (2004) (1050)
Acute kidney injury increases risk of ESRD among elderly. (2009) (1028)
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. (2005) (922)
Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. (1998) (894)
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. (2011) (841)
Projecting the number of patients with end-stage renal disease in the United States to the year 2015. (2005) (731)
Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. (2006) (704)
Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy (2003) (671)
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. (2012) (636)
Cognitive impairment in hemodialysis patients is common (2006) (582)
Hematocrit level and associated mortality in hemodialysis patients. (1999) (570)
The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study (2005) (507)
US Renal Data System 2013 Annual Data Report. (2014) (476)
US Renal Data System 2011 Annual Data Report (2012) (464)
End-stage renal disease in the United States: an update from the United States Renal Data System. (2007) (451)
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. (2008) (442)
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. (2003) (431)
Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. (2005) (411)
Octogenarians and Nonagenarians Starting Dialysis in the United States (2007) (408)
US Renal Data System 2012 Annual Data Report. (2013) (398)
Uric acid and long-term outcomes in CKD. (2009) (393)
Excerpts from the US Renal Data System 2009 Annual Data Report. (2010) (392)
US Renal Data System 2010 Annual Data Report. (2011) (386)
C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. (2005) (379)
Long interdialytic interval and mortality among patients receiving hemodialysis. (2011) (370)
Mortality risks of peritoneal dialysis and hemodialysis. (1999) (368)
Comparative Survival of Dialysis Patients in the United States After Coronary Angioplasty, Coronary Artery Stenting, and Coronary Artery Bypass Surgery and Impact of Diabetes (2002) (351)
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. (2002) (346)
Chronic kidney disease and cardiovascular disease in the Medicare population. (2003) (338)
The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. (2003) (337)
United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease (2015) (337)
Serum phosphorus levels associate with coronary atherosclerosis in young adults. (2009) (333)
Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. (2010) (323)
Urea index and other predictors of hemodialysis patient survival. (1994) (319)
Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. (2001) (317)
Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. (2005) (307)
Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. (2001) (304)
Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. (2005) (300)
Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians. (2004) (299)
Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? (2006) (297)
The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. (2004) (289)
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. (2016) (283)
Adiponectin and mortality in patients with chronic kidney disease. (2006) (268)
The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. (2009) (265)
Hypertension awareness, treatment, and control in chronic kidney disease. (2008) (265)
An improved comorbidity index for outcome analyses among dialysis patients. (2010) (265)
Excerpts from the United States Renal Data System 2006 Annual Data Report. (2007) (263)
United States Renal Data System 2008 Annual Data Report. (2009) (263)
Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. (2006) (262)
Lean body mass estimation by creatinine kinetics. (1994) (254)
Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. (2008) (253)
Hematocrit levels and hospitalization risks in hemodialysis patients. (1999) (244)
Atrial Fibrillation and Stroke in the General Medicare Population: A 10-Year Perspective (1992 to 2002) (2006) (235)
Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes (2017) (234)
Cardiovascular Mortality in End-Stage Renal Disease (2003) (233)
Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). (2007) (232)
Kidney Function and Sarcopenia in the United States General Population: NHANES III (2007) (218)
Excerpts from the United States Renal Data System 2007 annual data report. (2008) (204)
Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. (2006) (203)
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. (2009) (202)
End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. (2005) (201)
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. (2005) (200)
Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease (2007) (197)
Infectious complications in chronic kidney disease. (2006) (195)
CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. (2008) (190)
Cardiovascular disease in pediatric chronic dialysis patients. (2002) (188)
Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. (2005) (188)
Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. (2001) (185)
Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. (2012) (183)
A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. (1995) (181)
Hemoglobin level variability: associations with mortality. (2008) (180)
Body size and outcomes on peritoneal dialysis in the United States. (2003) (176)
Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. (2008) (175)
Long-Term Survival of Dialysis Patients in the United States With Prosthetic Heart Valves: Should ACC/AHA Practice Guidelines on Valve Selection Be Modified? (2002) (171)
Fabry Disease , an UnderRecognized Multisystemic Disorder : Expert Recommendations for Diagnosis , Management , and Enzyme Replacement Therapy (2003) (162)
Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. (1999) (162)
Effect of comorbidity on the increased mortality associated with early initiation of dialysis. (2005) (161)
Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study. (2005) (161)
Septicemia in the United States dialysis population, 1991 to 1999. (2004) (152)
Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. (2006) (151)
CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. (2008) (150)
Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. (2010) (145)
Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality. (1990) (138)
The USRDS: what you need to know about what it can and can't tell us about ESRD. (2013) (132)
Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study. (2003) (129)
Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. (2003) (128)
Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. (2015) (125)
Anaemia management prior to dialysis: cardiovascular and cost-benefit observations. (2003) (124)
Does predialysis nephrology care influence patient survival after initiation of dialysis? (2005) (123)
A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. (2005) (123)
Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. (2004) (123)
Serum bicarbonate and long-term outcomes in CKD. (2010) (121)
Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. (2005) (121)
Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US (2017) (120)
Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis. (2005) (120)
K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease: Work group membership (2005) (118)
Influenza vaccine delivery and effectiveness in end-stage renal disease. (2003) (117)
Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004. (2009) (116)
Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). (2009) (116)
The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. (2004) (116)
Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. (2007) (115)
Cardiovascular disease in end-stage renal disease patients. (2001) (115)
Low birth weight is associated with chronic kidney disease only in men. (2008) (114)
Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. (2002) (114)
Impact of hematocrit on morbidity and mortality. (2000) (112)
Chronic kidney disease: common, harmful and treatable--World Kidney Day 2007. (2007) (108)
Trends in anemia at initiation of dialysis in the United States. (2001) (105)
Acute variation in cognitive function in hemodialysis patients: a cohort study with repeated measures. (2007) (105)
Excerpts from the United States Renal Data System 1996 Annual Data Report. (2003) (100)
Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. (2008) (99)
Long-Term Outcome of Renal Transplant Recipients in the United States After Coronary Revascularization Procedures (2004) (98)
Trends in anemia treatment with erythropoietin usage and patient outcomes. (1998) (97)
Multicenter clinical validation of an on-line monitor of dialysis adequacy. (1996) (96)
Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease. (2009) (94)
A comparison of transplant outcomes in peritoneal and hemodialysis patients. (2003) (94)
Early mortality in patients starting dialysis appears to go unregistered. (2014) (91)
Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients. (2004) (89)
Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. (2007) (88)
Excerpts from the United States Renal Data System 1998 Annual Data Report. (1998) (88)
Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study. (2006) (88)
Coronary artery bypass surgery in patients on maintenance dialysis: long-term survival. (1988) (87)
Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization. (2001) (87)
Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention? (2008) (86)
United States Renal Data System assessment of the impact of the National Kidney Foundation-Dialysis Outcomes Quality Initiative guidelines. (2002) (85)
Pneumonia in incident dialysis patients--the United States Renal Data System. (2007) (84)
Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. (2007) (83)
Influence of target hemoglobin in dialysis patients on morbidity and mortality. (2002) (83)
Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes. (2005) (82)
Hemodialysis access at initiation in the United States, 2005 to 2007: Still “Catheter First” (2009) (82)
Global challenges posed by the growth of end-stage renal disease (2016) (80)
Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. (2009) (75)
Acute promyelocytic leukemia. Management of the coagulopathy during daunorubicin-prednisone remission induction. (1978) (75)
Screening populations at increased risk of CKD: the Kidney Early Evaluation Program (KEEP) and the public health problem. (2009) (74)
Hospital treatment for fluid overload in the Medicare hemodialysis population. (2010) (74)
Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study. (2016) (73)
CKD: common, harmful, and treatable--World Kidney Day 2007. (2007) (72)
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease. (2010) (72)
Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. (2015) (71)
Kidney dialysis treatment for victims of the Armenian earthquake. (1989) (70)
Chronic kidney disease: the distribution of health care dollars. (2004) (69)
Peritoneal and hemodialysis: II. Mortality risk associated with initial patient characteristics. (2002) (69)
Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. (2016) (68)
Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. (2005) (68)
Body mass index and mortality in CKD. (2007) (68)
Hypertension in pediatric long-term hemodialysis patients in the United States. (2009) (67)
Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United States. (2004) (66)
Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. (2008) (66)
Relationship Between Homocysteine and Mortality in Chronic Kidney Disease (2006) (65)
Atherosclerotic Renovascular Disease in Older US Patients Starting Dialysis, 1996 to 2001 (2006) (65)
Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients. (2004) (63)
Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States. (2004) (63)
Hospitalization during advancing chronic kidney disease. (2003) (62)
Atherosclerotic renovascular disease in the United States. (2010) (61)
Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. (2000) (59)
Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis. (2011) (58)
The impact of residual renal function on graft and patient survival rates in recipients of preemptive renal transplants. (2003) (58)
Statistical methods for comparing mortality among ESRD patients: Examples of regional/international variations (2000) (57)
Statistical methods for comparing mortality among ESRD patients: Examples of regional/international variations (2000) (57)
Comparison and Survival of Hemodialysis and Peritoneal Dialysis in the Elderly (2002) (57)
Statistical methods for comparing mortality among ESRD patients: Examples of regional/international variations (2000) (57)
General medical care among patients with chronic kidney disease: opportunities for improving outcomes. (2005) (57)
CKD surveillance using administrative data: impact on the health care system. (2009) (55)
NHANES III: influence of race on GFR thresholds and detection of metabolic abnormalities. (2007) (54)
Renal failure in disasters. (1991) (54)
On-pump versus off-pump coronary surgery outcomes in patients requiring dialysis: perspectives from a single center and the United States experience. (2006) (53)
Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients. (1995) (53)
Hematocrit levels and associated Medicare expenditures. (2000) (53)
Anemia and Cardiovascular Disease, Hospitalization, End Stage Renal Disease, and Death in Older Patients with Chronic Kidney Disease (2004) (53)
Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease? (2005) (52)
United States Renal Data System 2007 Annual Data Report Abstract (2008) (52)
Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies. (2012) (52)
Establishing the Global Kidney Disease Prevention Network (KDPN): a position statement from the National Kidney Foundation. (2011) (52)
Dialysis unit and patient characteristics associated with reuse practices and mortality: 1989-1993. (1998) (52)
United States Renal Data System 2006 Annual Data Report Abstract (2007) (51)
The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients. (2011) (51)
Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy. (2002) (51)
Prevalence of anemia in erythropoietin-treated pediatric as compared to adult chronic dialysis patients. (2004) (50)
The growing economic burden of diabetic kidney disease (2009) (50)
Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. (2008) (50)
5-Azacytidine and renal tubular dysfunction. (1981) (49)
International dialysis aid in earthquakes and other disasters. (1993) (49)
Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect? (2004) (49)
National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2009: executive summary. (2010) (48)
Temporal trends in red blood transfusion among US dialysis patients, 1992-2005. (2008) (48)
Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. (2004) (47)
Kidney Early Evaluation Program (KEEP) (2004) (46)
Hospitalization risks between Renagel phosphate binder treated and non-Renagel treated patients. (2000) (46)
Long-term survival of dialysis patients with bacterial endocarditis in the United States. (2004) (46)
Serum Phosphate and Left Ventricular Hypertrophy in Young Adults: The Coronary Artery Risk Development in Young Adults Study (2009) (45)
Relationship between epoetin alfa dose and mortality: findings from a marginal structural model. (2010) (45)
Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform. (2016) (45)
Scope and design of the Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements (FREEDOM) Study. (2009) (44)
Disposition of vancomycin during hemofiltration (1986) (44)
Peritoneal and hemodialysis: I. Differences in patient characteristics at initiation. (2002) (44)
Determination of residual renal function with iohexol clearance in hemodialysis patients. (1996) (43)
Chronic kidney disease awareness, screening and prevention: Rationale for the design of a public education program (2010) (42)
KDOQI Hypertension, Dyslipidemia, and Diabetes Care Guidelines and Current Care Patterns in the United States CKD Population: National Health and Nutrition Examination Survey 1999–2004 (2009) (42)
Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. (1990) (42)
ESRD from lupus nephritis in the United States, 1995-2010. (2015) (41)
Evaluation of disease-state management of dialysis patients. (2001) (41)
Anemia and new-onset congestive heart failure in the general Medicare population. (2005) (40)
Association of preventive health care with atherosclerotic heart disease and mortality in CKD. (2009) (39)
Clinical Epidemiology of Long-bone Fractures in Patients Receiving Hemodialysis (2006) (38)
Trends in intravenous iron use among dialysis patients in the United States (1994-2002). (2005) (38)
Hemoglobin variability and mortality: confounding by disease severity. (2011) (38)
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP). (2011) (38)
Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death. (2008) (38)
Microbiologic contamination of liquid bicarbonate concentrate for hemodialysis. (1987) (37)
Rapid high-efficiency bicarbonate hemodialysis. (1986) (37)
The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis. (2016) (37)
Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitis. (1987) (36)
Fetuin-A is not associated with mortality in chronic kidney disease. (2007) (36)
Does cadaveric donor renal transplantation ever provide better outcomes than live-donor renal transplantation?1,2 (2003) (36)
One-Year Mortality Rates in US Children with End-Stage Renal Disease (2015) (36)
Rapid high-efficiency hemodialysis. (1986) (34)
ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010. (2014) (34)
Association of heart disease with diabetes and hypertension in patients with ESRD. (2005) (33)
EPO adjustments in patients with elevated hemoglobin levels: provider practice patterns compared with recommended practice guidelines. (2007) (33)
Fluid and hemodynamic management in hemodialysis patients: challenges and opportunities (2019) (33)
Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy. (2016) (33)
Meeting KDOQI guideline goals at hemodialysis initiation and survival during the first year. (2010) (33)
Host Defenses and Infectious Complications in Maintenance Hemodialysis Patients (1996) (33)
A simplified approach to monitoring in vivo therapy prescription. (1988) (32)
Quantification of hemodialysis: analysis of methods and the relevance to patient outcome. (1997) (31)
Chronic Kidney Disease: Common, Harmful and Treatable – World Kidney Day 2007 (2007) (31)
Peer kidney care initiative 2014 report: dialysis care and outcomes in the United States. (2015) (31)
Hemoglobin Level Variability: Anemia Management among Variability Groups (2009) (30)
Dysglycemia Predicts Cardiovascular and Kidney Disease in the Kidney Early Evaluation Program (2010) (30)
Provider and care characteristics associated with timing of dialysis initiation. (2014) (30)
SPECIAL ANNOUNCEMENT: World Kidney Day: An idea whose time has come (2006) (30)
Acute promyelocytic leukemia. Management of the coagulopathy during daunorubicin-prednisone remission induction: Management of the Coagulopathy During Daunorubicin-Prednisone Remission Induction (1978) (29)
Technical requirements for rapid high-efficiency therapies. (1986) (29)
Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes. (2020) (29)
Agreement of reported vascular access on the medical evidence report and on medicare claims at hemodialysis initiation (2014) (27)
Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels. (2006) (27)
Diagnosis of cardiac disease in pediatric end-stage renal disease. (2011) (27)
Sustainable community-based CKD screening methods employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP). (2011) (26)
The competing risks of death vs ESRD in Medicare beneficiaries 65+ with chronic kidney disease, CHF, and anemia (2002) (26)
Dialysis-Induced Cardiovascular and Multiorgan Morbidity (2020) (26)
Clinical epidemiology of parathyroidectomy in hemodialysis patients: The USRDS waves 1, 3, and 4 study (2007) (26)
Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics (2013) (25)
Insights From the 2016 Peer Kidney Care Initiative Report: Still a Ways to Go to Improve Care for Dialysis Patients. (2018) (25)
Effects of Monthly Dose and Regular Dosing of Intravenous Active Vitamin D Use on Mortality Among Patients Undergoing Hemodialysis (2009) (25)
Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population. (2019) (24)
Trends in Anemia Management Practices in Patients Receiving Hemodialysis and Peritoneal Dialysis: A Retrospective Cohort Analysis (2015) (24)
The renal replacement therapy landscape in 2030: reducing the global cardiovascular burden in dialysis patients (2020) (23)
Controlling confounding of treatment effects in administrative data in the presence of time‐varying baseline confounders (2016) (23)
Dialyser reuse-associated mortality and hospitalization risk in incident Medicare haemodialysis patients, 1998-1999. (2004) (22)
RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL. (2013) (22)
Relative risk of home hemodialysis attrition in patients using a telehealth platform (2018) (22)
Acute nonlymphocytic leukemia in patients with nodular lymphoma (1977) (22)
Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005. (2010) (22)
Kidney function and risk triage in adults: threshold values and hierarchical importance. (2011) (22)
KDIGO Board Members (2012) (21)
Reducing avoidable rehospitalization in ESRD: a shared accountability. (2014) (21)
Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANES. (2009) (21)
Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction. (2008) (21)
Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion. (2014) (20)
Improving Outcomes in Patients Receiving Dialysis: The Peer Kidney Care Initiative. (2016) (20)
World Kidney Day: an idea whose time has come (2006) (20)
United States Renal Data System 2005 Annual Data Report Abstract (2006) (20)
Meeting the World's Need for Maintenance Dialysis. (2015) (19)
Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program (2011) (19)
Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: A retrospective analysis (2008) (18)
Are there limitations to shortening dialysis treatment? (1988) (18)
Impact of disease severity and hematocrit level on reuse-associated mortality. (2000) (18)
Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003. (2007) (18)
Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis. (2020) (18)
Association of Mean Weekly Epoetin Alfa Dose with Mortality Risk in a Retrospective Cohort Study of Medicare Hemodialysis Patients (2011) (18)
Perihospitalization hemoglobin‐epoetin associations in U.S. hemodialysis patients, 1998 to 2003 (2007) (18)
Impact of congestive heart failure and other cardiac diseases on patient outcomes. (2002) (17)
Geovariation in Fracture Risk among Patients Receiving Hemodialysis. (2016) (17)
Predialysis Care and Dialysis Outcomes in Hemodialysis Patients with a Functioning Fistula (2014) (17)
Clinical factors associated with achieving K/DOQI hemoglobin targets in hemodialysis patients (2004) (16)
Guiding principles and checklist for population-based quality metrics. (2014) (16)
Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants. (2007) (16)
Methods for Estimating and Interpreting Provider-Specific Standardized Mortality Ratios (2003) (16)
Clinical comparison of hemodialysis and hemofiltration. (1985) (16)
Reuse-associated mortality in incident hemodialysis patients in the United States, 2000 to 2001. (2005) (15)
Readmissions Following a Hospitalization for Cardiovascular Events in Dialysis Patients: A Retrospective Cohort Study (2018) (15)
A new approach to optimizing urea clearances in hemodialysis and continuous ambulatory peritoneal dialysis. (1995) (15)
Screening for chronic kidney disease complications in US adults: racial implications of a single GFR threshold. (2008) (14)
Possible effects of the new Medicare reimbursement policy on African Americans with ESRD. (2009) (14)
Mortality from Cancer among US Hemodialysis Patients, 1995–2005 (2010) (14)
An Instrumental Variable Analysis of the Impact of Practice Guidelines on Improving Quality of Care and Diabetes-Related Outcomes in the Elderly Medicare Population (2008) (14)
Time to target haemoglobin concentration (11 g/dl)--risk of hospitalization and mortality among incident dialysis patients. (2007) (13)
National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2011: executive summary. (2012) (13)
Blood access without skin puncture. (1981) (13)
Association of provider-patient visit frequency and patient outcomes on hemodialysis. (2012) (13)
Advancing fluid management in peritoneal dialysis. (2002) (13)
Use of prophylactic growth factors and antimicrobials in elderly patients with cancer: a review of the Medicare database (2017) (12)
Impact of Centers for Medicare & Medicaid Services national coverage determination on erythropoiesis‐stimulating agent and transfusion use in chemotherapy‐treated cancer patients (2012) (12)
Erratum: Urea index and other predictors of hemodialysis patient survival (American Journal of Kidney Diseases (1994) 23 (272-282)) (1994) (12)
National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2010: executive summary. (2011) (12)
End-Stage Renal Disease Attributed to Acute Tubular Necrosis in the United States, 2001-2010 (2015) (12)
Participant follow-up in the Kidney Early Evaluation Program (KEEP) after initial detection. (2008) (12)
Impact of Renal Disease on Patients with Hepatitis C: A Retrospective Analysis of Disease Burden, Clinical Outcomes, and Health Care Utilization and Cost (2017) (12)
Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients. (2009) (11)
Blood access without percutaneous punctures. (1980) (11)
Shortening of the hemodialysis procedure and mortality in "healthy" dialysis patients. (1990) (11)
State-level adjusted ESRD incident rates: use of observed vs model-predicted category-specific rates. (2006) (11)
World Kidney Day: an idea whose time has come. (2006) (11)
Race and end‐stage renal disease in the United States Medicare population: The disparity persists (2008) (11)
The Healthy People 2020 Objectives for Kidney Disease: How Far Have We Come, and Where Do We Need to Go? (2017) (11)
Relative safety of peginesatide and epoetin alfa (2014) (11)
Long Overdue Need to Reduce Infections with Hemodialysis. (2017) (10)
Executive summary: Kidney Early Evaluation Program (KEEP) 2007 Annual Data Report. (2008) (10)
Volume of urea cleared as a therapy dosing guide for more frequent hemodialysis (2018) (9)
High efficiency hemodialysis. (1989) (9)
Development of a standardized transfusion ratio as a metric for evaluating dialysis facility anemia management practices. (2014) (9)
Anemia and cost in Medicare patients with congestive heart failure. (2006) (8)
Identifying High-Risk Individuals for Chronic Kidney Disease: Results of the CHERISH Community Demonstration Project (2018) (8)
Genetic and environmental effects and characteristics of Japanese end‐stage renal disease patients (2009) (8)
Creatinine-Based Glomerular Filtration Rates and Microalbuminuria for Detecting Metabolic Abnormalities in US Adults: The National Health and Nutrition Examination Survey 2003–2004 (2007) (8)
Abstract 13320: Effect of Cardiovascular Comorbidities on the Mortality Risk Associated with Serum Potassium (2014) (8)
Infectious complications in patients with chronic kidney disease. (2006) (8)
European Renal Association – European Dialysis and Transplant Association ( ERA – EDTA ) Congress in Copenhagen , Denmark Chairperson : (2018) (8)
Central on-site preparation of substitution fluid for hemofiltration. (1984) (7)
Urgent: Stop Preventable Infections Now. (2018) (7)
Effect of Ticarcillin on Gentamicin and Tobramycin Pharmacokinetics in a Patient with End‐stage Renal Disease (1984) (7)
Predictors of ESA Use in the Non-Dialysis Chronic Kidney Disease Population with Anemia (2009) (7)
Executive summary: Kidney Early Evaluation Program (KEEP) 2008 annual data report. (2009) (7)
Assessment of pure red cell aplasia in US dialysis patients: the limits of the Medicare data. (2004) (7)
Chronic kidney disease: common, harmful, and treatable--World Kidney Day 2007. (2007) (7)
Effects of the prospective payment system on anemia management in maintenance dialysis patients: implications for cost and site of care (2016) (7)
The longitudinal cost of end-stage renal disease in persons with diabetes in the United States (2004) (7)
Effects of Epoetin Alfa Titration Practices, Implemented After Changes to Product Labeling, on Hemoglobin Levels, Transfusion Use, and Hospitalization Rates. (2016) (6)
Co-trending of parathyroid hormone and phosphate in patients receiving hemodialysis. (2016) (6)
Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer (2017) (6)
How Can the Mortality Rate of Chronic Dialysis Patients Be Reduced? (1993) (6)
Repeatable access blood flow (ABF) measurement. (1984) (6)
Hemodialysis Patient Outcomes: Provider Characteristics (2014) (6)
Cystatin C, mortality risk and clinical triage in US adults: threshold values and hierarchical importance. (2011) (6)
Patient characteristics, disease burden, and medication use in stage 4 - 5 chronic kidney disease patients. (2016) (6)
Acid–base kinetics during hemodialysis using bicarbonate and lactate as dialysate buffer bases based on the H+ mobilization model (2020) (6)
Associations of anemia persistency with medical expenditures in Medicare ESRD patients on dialysis (2009) (6)
End-stage renal disease (2000) (6)
Using more frequent haemodialysis to manage volume overload in dialysis patients with heart failure, obesity or pregnancy (2020) (6)
Reduced treatment time: hemodialysis (HD) versus hemofiltration (HF). (1985) (6)
Open Forum: shortened dialysis (1986) (5)
Adequacy, benefits, complications, dose and efficacy of filtration - the minneapolis experience (1984) (5)
A Novel Model of Cardiovascular Risk Based on Kidney Function (2011) (5)
Geographic variation of parathyroidectomy in patients receiving hemodialysis: a retrospective cohort analysis (2016) (5)
Effect of dialysate potassium and lactate on serum potassium and bicarbonate concentrations during daily hemodialysis at low dialysate flow rates (2019) (5)
World Kidney Day: an idea whose time has come. (2006) (5)
Acute myocardial infarction in chronic dialysis patients (1996) (5)
Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis (2016) (4)
Hemodialysis: How Much Is Enough? (1988) (4)
Reaching Target Hemoglobin after Hospitalization for Incident Hemodialysis Patients (2004) (4)
End-stage renal disease from human immunodeficiency virus–associated nephropathy in the United States, 2001 through 2010. (2014) (4)
Intensive Hemodialysis: Time to Give the Therapy Greater Consideration. (2016) (4)
Title Page. Should Hemoglobin Targets for Anemic Patients with Chronic Kidney Disease Be Changed? (2010) (4)
A decade after the KDOQI CKD guidelines: impact on the United States and global public policy. (2012) (4)
Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: a retrospective cohort study (2015) (4)
Chronic kidney disease: common, harmful and treatable—World Kidney Day 2007 (2007) (4)
Planning of Dialysis for Disasters (1996) (3)
Dialytic therapy in the management of chronic renal failure. (1984) (3)
Predictors of Provider-Patient Visit Frequency during Hemodialysis (2013) (3)
Exceeding hemoglobin target levels in US hemodialysis patients receiving epoetin, 1999 to 2002 (2007) (3)
World Kidney Day: An idea whose time has come (Editorial) (2006) (3)
Contemporary Trends in Clinical Outcomes among Dialysis Patients with Medicare Coverage (2019) (3)
World Kidney Day: an idea whose time has come. (2006) (3)
Growth of the ESKD Population: Progress or Peril? (2018) (2)
The US Renal Data System "Pie Chart of Death". (2016) (2)
Changes and alternatives for dialysis facilities under the bundled payment plan. (2013) (2)
Dialysis and End-Stage Kidney Disease (2019) (2)
Shaping Public Health Initiatives in Kidney Diseases: The Peer Kidney Care Initiative (2016) (2)
In Reply to ‘Prevalence of CKD in the United States: GFR-Estimating Equations Matter' (2009) (1)
Timing of Primary Prophylaxis G-CSF Use during Chemotherapy in Elderly Patients with NHL (2014) (1)
More frequent dialysis and the role of medical justification in a MAC world. (2016) (1)
Survival of dialysis patients after cardiac arrest in the United States: The impact of implantable cardioverter defibrillators (2003) (1)
162: Chronic Kidney Disease and Cardiovascular Disease in Volunteer and Randomly Selected Populations: KEEP and NHANES (2008) (1)
Optimizing serum total carbon dioxide concentration during short and nocturnal frequent hemodialysis using lactate as dialysate buffer base (2020) (1)
New Strategies for High Efficiency Hemodialysis (1989) (1)
347 Relative Mortality in Daily Home and Matched, Thrice-Weekly In-Center Hemodialysis Patients (2011) (1)
Declining renal function in persons of different race without chronic kidney disease. (2011) (1)
Home dialysis in Japan. Introduction. (2012) (1)
354 Disease State Awareness, Kidney Disease, and Relationship to ESRD and Death (2011) (1)
Sharing knowledge on dialysis registries worldwide (2015) (1)
Severe renal tubular dysfunction during 5-azacytidine chemotherapy (1979) (1)
SaO042ULTRAFILTRATION RATE IS POSITIVELY ASSOCIATED WITH MORTALITY RISK IN HOME HEMODIALYSIS PATIENTS (2018) (1)
FP541ACID-BASE HOMEOSTASIS DURING HEMODIALYSIS USING BICARBONATE AND LACTATE AS DIALYSATE BUFFERS (2019) (1)
Association between hematocrit levels and mortality in hemodialysis patients. (2000) (1)
Clinical Factors Associated with Changing Hematocrit Levels in Hemodialysis Patients (1999) (1)
SUN-050 STRATIFICATION OF CARDIOVASCULAR DEATH RISK BY ARRHYTHMIA, HEART FAILURE, AND DIABETES IN A PREVALENT COHORT OF DIALYSIS PATIENTS IN THE UNITED STATES (2019) (1)
Economic Effect of Following HbA1c Testing Practice Guidelines in the Elderly Medicare Population: An Instrumental Variable Analysis (2010) (1)
Effect of Inflammation on the Relationship of Pulse Pressure and Mortality in Haemodialysis (2012) (1)
The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients (2004) (1)
World Kidney Day: an idea whose time has come. (2006) (1)
End‐stage renal disease from hemolytic uremic syndrome in the United States, 1995–2010 (2015) (1)
KEEP 2009: Tenth anniversary of the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) (2010) (1)
Intensive Hemodialysis: Potential for Improving Patient Outcomes (2016) (1)
127: Association of Chronic Kidney Disease with Birth Weight and Gender in the Kidney Early Evaluation Program Participants (2007) (0)
Response to Letter Regarding Article, “Relationship Between Homocysteine and Mortality in Chronic Kidney Disease” (2006) (0)
138: Longitudinal Cost Analysis of Chronic Kidney Patients in Taiwan (2007) (0)
nfectious Complications in Chronic Kidney isease (2006) (0)
Subject Index Vol. 30, 2009 (2009) (0)
Mortality among women diagnosed with stage II or III breast cancer based on SEER-Medicare data. (2014) (0)
288: K-DOQI Guideline Goal Attainment at Hemodialysis Initiation and First-Year Survival (2010) (0)
214: Association Between Mortality and Modality in the First 90 Days Following Initiation of Dialysis (2007) (0)
142: Effects of Use Patterns of Intravenous Vitamin D on All-Cause Mortality in Prevalent Hemodialysis Patients (2008) (0)
Chapter 1 – Demographics of the End-Stage Renal Disease Patient (2016) (0)
163: Racial and Gender Differences in Prevalence and Predictors of Anemia of Chronic Kidney Disease: KEEP and NHANES 1999-2004 (2008) (0)
Contents Vol. 30, 2009 (2009) (0)
Acknowledgement to Reviewers (2012) (0)
Coping With Chronic Kidney Disease (2007) (0)
139: Traansplanation Hospitalization and Quality of Care for ESRD Patients in Taiwan from 1996-2004 (2007) (0)
151: Uric Acid and Long-Term Outcomes in Chronic Kidney Disease (2008) (0)
Optimal Definition of Chronic Kidney Disease as a Cardiovascular Risk State (2008) (0)
The authors reply. (2013) (0)
World Kidney Day: an idea whose time has come. (2006) (0)
Erratum: Cardiovascular disease in pediatric chronic dialysis patients (Kidney International (2002) 62 (648-653)) (2003) (0)
FRACTIONAL EXCRETION OF UREA (FEur), NKF-DOQI GUIDELINES FOR INITIATION OF DIALYSIS & EFFECT ON US ESRD POPULATION (2002) (0)
Transfusion trends in chemotherapy-induced anemia: Observation from the Medicare 5% Sample, 1992–2005 (2008) (0)
367 Peginesatide Phase 3 Trial Subjects vs. a Random Sample of United States Hemodialysis Patients (2011) (0)
Oral Antimicrobial Drug Use during Chemotherapy in Medicare Enrollees with NHL (2014) (0)
Care of the Chronic Hemodialysis Patient (1983) (0)
P-310: Uncontrolled hypertension and chronic kidney disease in the keep study (2004) (0)
Chapter 47 – Chronic Kidney Disease: Cost of Care in this High-Risk Outlier Population (2005) (0)
The effect of diabetes on incidence and mortality in end-stage renal disease in Germany (2011) (0)
Supplementary Material for: Trends in Anemia Management Practices in Patients Receiving Hemodialysis and Peritoneal Dialysis: A Retrospective Cohort Analysis (2015) (0)
FP440NOCTURNAL HOME HEMODIALYSIS WITH LOW-FLOW DIALYSATE (2018) (0)
Hct levels fall rapidly if anemia management is not started at the initiation of dialysis. (ANNA National Symposium Abstracts) (2003) (0)
home hemodialysis program training volume, transplant incidence, and attrition due to patient burden (2016) (0)
Clinical aspects of high efficiency hemodialysis. (1988) (0)
K/doqi Tm Disclaimer K/doqi Advisory Board Members K/doqi Tm Nutrition Work Group Membership Adult Work Group Members Pediatric Work Group Members Nkf-doqi Advisory Council* Nkf-doqi Steering Committee* Acronyms and Abbreviations List Abbreviation Term A1-ag A1-acid Glycoprotein Abw Ef Adjusted Edem (0)
Trends in the use of adjuvant anthracycline- and taxane-based chemotherapy regimens in early-stage breast cancer, by surgery type. (2014) (0)
Consultants for the American Journal of Nephrology 2009 (2009) (0)
Vascular calcification in CKD: basic and clinical developments SO12 CORONARY ARTERY CALCIFICATION PROGRESSION IN RENAL TRANSPLANT RECIPIENTS (2005) (0)
Multicentre clinical experience with the Hemasite blood access device (1983) (0)
34: Adjustment for Exposure History and Important Confounders Markedly Attenuates Elevated Mortality Risk Associated with Epoetin Alfa (EPO) Dose (2008) (0)
215: The Association of Persistently Low Hemoglobin Levels with Hospitalization and Mortality (2007) (0)
005: The Pattern of Renal Failure to End-Stage Renal Disease (2005) (0)
Friedman, JH, 167 Friedman, N., 165 (2002) (0)
Contents Vol. 34, 2011 (2011) (0)
Using Discrete Recurrence Quantification Analysis to Probe the Dynamics of Decision Making (0)
212: Consistent In-Target Hemoglobin Over the Transition to Dialysis: Effect on Outcomes (2007) (0)
How Should Dialyzers Be Reprocessed? (1998) (0)
Mortality Risk between For‐Profit and Not‐For‐Profit Dialysis Facilities (2004) (0)
10: Predictors of Consistent In-Target Hemoglobin Over the Transition to Dialysis (2007) (0)
Impact of prior myocardial infarction and vascular disease on the risk of subsequent cardiac events among 68 730 patients commencing dialysis. (2002) (0)
Supplementary Material for: Impact of Renal Disease on Patients with Hepatitis C: A Retrospective Analysis of Disease Burden, Clinical Outcomes, and Health Care Utilization and Cost (2017) (0)
Fred L. Shapiro, MD 1934–2004 (2004) (0)
What Dialysis is Best for Diabetic Patients — Hemodialysis or CAPD? (1991) (0)
66: The Association of Iron Administration with Hemoglobin Overshooting (2007) (0)
89: Identification of Patients with CKD Using Medicare Data: Inpatient vs. Outpatient Claims (2008) (0)
CHAPTER 1 – Demographics of the End-Stage Renal Disease Population (2008) (0)
Racial and Ethnic Differences in Developing End-Stage Renal Disease (2004) (0)
Pregnancy, antepartum complication, and outcome rates in the dialysis and renal transplant populations (2005) (0)
Abstract 3749: Chronic Kidney Disease and Risk for Premature Cardiovascular Disease (2007) (0)
Contents Vol. 31, 2010 (2010) (0)
Supplementary Material for: One-Year Mortality Rates in US Children with End-Stage Renal Disease (2017) (0)
Abstract P3-07-29: Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early stage breast cancer (2015) (0)
Subject Index Vol. 31, 2010 (2010) (0)
Peracetic acid reuse as a risk factor for hemodialysis patient survival (1994) (0)
104: Trends in Stroke Rates Among Hemodialysis Patients (2010) (0)
implementation strategies in low-and Understanding kidney care needs and middle-income countries : conclusions from a “ Kidney Disease : Improving Global Outcomes ” ( KDIGO ) Controversies Conference (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Allan J. Collins?

Allan J. Collins is affiliated with the following schools:

University of Minnesota
University of Utah